NCT06038760 Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO) Status TERMINATED Phase N/A
NCT06017063 Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields Status NOT_YET_RECRUITING Phase NA
NCT05990556 Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients Status RECRUITING Phase NA
NCT05979064 Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) Status RECRUITING Phase NA
NCT05974410 Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Status AVAILABLE Phase N/A
NCT05970757 Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT05954858 Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma Status RECRUITING Phase NA
NCT05938387 Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma Status COMPLETED Phase PHASE1
NCT05929456 Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid) Status UNKNOWN Phase PHASE1
NCT05927610 Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma Status WITHDRAWN Phase NA
NCT05917145 ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma Status RECRUITING Phase PHASE1
NCT05902169 Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM Status RECRUITING Phase PHASE3
NCT05900908 Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy Status WITHDRAWN Phase PHASE4
NCT05879367 Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma Status RECRUITING Phase PHASE1
NCT05873946 Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery Status COMPLETED Phase N/A
NCT05871021 Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma Status RECRUITING Phase PHASE2
NCT05843253 Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant Status RECRUITING Phase PHASE2